Why Is Relmada Therapeutics Stock Soaring Monday?

Relmada Therapeutics Inc. (NASDAQ:RLMD) shares are up during Monday’s premarket session following the release of promising interim data from its Phase 2 trial of NDV-01 for treating non-muscle invasive bladder cancer. Bladder Cancer Trial Data The 12-month interim...

Top 3 Materials Stocks That May Crash This Month

As of March 9, 2026, three stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its...